Azaquinazoline inhibitors of Atypical protein Kinase C
US9914730B2 · kind B2 · utility
3Cited by
1References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 27, 2013 |
| Grant date | Mar 13, 2018 |
| Priority date | — |
| Expiry date | Feb 24, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F9/6584
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present application provides azaquinazoline compounds as defined herein. This application further describes compositions comprising the same. These azaquinazoline compounds and their salts have atypical protein kinase C (“aPKC”) inhibitory activity, and may be used to treat proliferative disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.